Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells

Neuropharmacology - Tập 54 - Trang 45-50 - 2008
Monica Bari1, Sergio Oddi2,3, Chiara De Simone1,2, Paola Spagnolo1, Valeria Gasperi2,3, Natalia Battista3, Diego Centonze2,4, Mauro Maccarrone2,3
1Department of Experimental Medicine and Biochemical Sciences, University of Rome “Tor Vergata”, 00133 Rome, Italy
2European Center for Brain Research (CERC)/IRCCS, S. Lucia Foundation, 00196 Rome, Italy
3Department of Biomedical Sciences, University of Teramo, 64100 Teramo, Italy
4Neurologic Clinics, Department of Neurosciences, University of Rome ‘Tor Vergata’, 00133 Rome, Italy

Tài liệu tham khảo

Arcangeli, 2006, Complex functional interaction between integrin receptors and ion channels, Trends Cell Biol., 16, 631, 10.1016/j.tcb.2006.10.003 Bari, 2005, Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis, J. Biol. Chem., 280, 12212, 10.1074/jbc.M411642200 Bari, 2006, New insights into endocannabinoid degradation and its therapeutic potential, Mini Rev. Med. Chem., 6, 257, 10.2174/138955706776073466 Bari, 2006, Effect of lipid rafts on CB2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells, J. Immunol, 177, 4971, 10.4049/jimmunol.177.8.4971 Barnett-Norris, 2005, Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system, Life Sci., 77, 1625, 10.1016/j.lfs.2005.05.040 Bifulco, 2002, Targeting the endocannabinoid system in cancer therapy: a call for further research, Nat. Med., 8, 547, 10.1038/nm0602-547 Bisogno, 2003, Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid knockout in the brain, J. Cell Biol., 163, 463, 10.1083/jcb.200305129 Biswas, 2003, Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis, Hepatology, 38, 1167, 10.1053/jhep.2003.50459 Cameron, 2002, Caveolin-1 expression is maintained in rat and human astroglioma cell lines, Glia, 37, 275, 10.1002/glia.10036 Carracedo, 2004, Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids, Biochem. J., 380, 435, 10.1042/bj20031714 Di Marzo, 2006, A brief history of cannabinoid and endocannabinoid pharmacology as inspired by the work of British scientists, Trends Pharmacol. Sci., 27, 134, 10.1016/j.tips.2006.01.010 Dinh, 2002, Brain monoglyceride lipase participating in endocannabinoid inactivation, Proc. Natl. Acad. Sci. U.S.A., 99, 10819, 10.1073/pnas.152334899 Egertova, 2003, Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signalling, Neuroscience, 119, 481, 10.1016/S0306-4522(03)00145-3 Fowler, 2005, Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptors, Curr. Drug Targets CNS Neurol Disord., 4, 685, 10.2174/156800705774933041 Gajate, 2001, The antitumor ether lipid ET-18-OCH(3) induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells, Blood, 98, 3860, 10.1182/blood.V98.13.3860 Gajate, 2005, Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy, J. Biol. Chem., 280, 11641, 10.1074/jbc.M411781200 Galve-Roperh, 2000, Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation, Nat. Med., 6, 313, 10.1038/73171 Giang, 1997, Molecular characterization of human and mouse fatty acid amide hydrolase, Proc. Natl. Acad. Sci. U.S.A., 94, 2238, 10.1073/pnas.94.6.2238 Guzman, 2003, Cannabinoids: potential anticancer agents. Nature Rev, Cancer, 3, 745 Hashimoto, 2003, Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease, J. Neurochem., 85, 1468, 10.1046/j.1471-4159.2003.01791.x Hinz, 2004, R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts, Biochem. Biophys. Res. Commun., 324, 621, 10.1016/j.bbrc.2004.09.095 Howlett, 2005, Cannabinoid receptor signaling, Handb. Exp. Pharmacol., 168, 53, 10.1007/3-540-26573-2_2 Hsieh, 1999, Internalization and recycling of the CB1 cannabinoid receptor, J. Neurochem., 73, 493, 10.1046/j.1471-4159.1999.0730493.x Klein, 2003, The cannabinoid system and immune modulation, J. Leukoc. Biol., 74, 486, 10.1189/jlb.0303101 Kunzelmann-Marche, 2002, Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway, J. Biol. Chem., 277, 19876, 10.1074/jbc.M200324200 Leterrier, 2004, Constitutive endocytic cycle of the CB1 cannabinoid receptor, J. Biol. Chem., 279, 36013, 10.1074/jbc.M403990200 Maccarrone, 2006, Involvement of the endocannabinoid system in cancer Maccarrone, 2005, Anandamide uptake by human endothelial cells and its regulation by nitric oxide, J. Biol. Chem., 275, 13484, 10.1074/jbc.275.18.13484 Maccarrone, 2007, The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases, Prog. Neurobiol., 81, 349, 10.1016/j.pneurobio.2006.11.006 McFarland, 2005, Lipid rafts: a nexus for endocannabinoid signaling?, Life Sci., 77, 1640, 10.1016/j.lfs.2005.05.010 McKinney, 2005, Structure and function of fatty acid amide hydrolase, Annu. Rev. Biochem., 74, 411, 10.1146/annurev.biochem.74.082803.133450 Mechoulam, 2002, Cannabinoids and brain injury: therapeutic implications, Trends Mol. Med., 8, 58, 10.1016/S1471-4914(02)02276-1 Nunez, 2004, Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study, Synapse, 53, 208, 10.1002/syn.20050 Okamoto, 1998, Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane, J. Biol. Chem., 273, 5419, 10.1074/jbc.273.10.5419 Okamoto, 2004, Molecular characterization of a phospholipase D generating anandamide and Its congeners, J. Biol. Chem., 279, 5298, 10.1074/jbc.M306642200 Pike, 2003, Lipid rafts: bringing order to chaos, J. Lipid Res., 44, 655, 10.1194/jlr.R200021-JLR200 Piomelli, 2003, The molecular logic of endocannabinoid signalling, Nat. Rev. Neurosci., 4, 873, 10.1038/nrn1247 Rodgers, 2005, Merging complexes: properties of membrane raft assembly during lymphocyte signaling, Trends Immun., 26, 97, 10.1016/j.it.2004.11.016 Rybin, 2000, Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway, J. Biol. Chem., 275, 41447, 10.1074/jbc.M006951200 Sànchez, 2001, The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein FAN, Mol. Pharmacol., 59, 955, 10.1124/mol.59.5.955 Sarker, 2003, Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts, Cell. Mol. Life Sci., 60, 1200, 10.1007/s00018-003-3055-2 Sarnataro, 2005, Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells, FEBS Lett., 579, 6343, 10.1016/j.febslet.2005.10.016 Sarnataro, 2006, The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism, Mol. Pharmacol., 70, 1298, 10.1124/mol.106.025601 Shajahan, 2007, Caveolin-1 tyrosine phosphorylation enhances paclitaxel-mediated cytotoxicity, J. Biol. Chem., 282, 5934, 10.1074/jbc.M608857200 Silva, 1999, Identification of caveolae and caveolin in C6 glioma cells, Int. J. Dev. Neurosci., 17, 705, 10.1016/S0736-5748(99)00040-4 Simons, 2002, Cholesterol, lipid rafts, and disease, J. Clin. Invest., 110, 597, 10.1172/JCI0216390 Simons, 2000, Lipid rafts and signal transduction, Nat. Rev. Mol. Cell. Biol., 1, 31, 10.1038/35036052 Smythe, 2003, A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes, J. Cell Sci., 116, 4739, 10.1242/jcs.00806 Song, 1996, Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains, J. Biol. Chem., 271, 9690, 10.1074/jbc.271.16.9690 Sotgia, 2006, Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers, Cancer Res., 66, 10647, 10.1158/0008-5472.CAN-06-2805 Terrinoni, 2004, p73-alpha is capable of inducing scotin and ER stress, Oncogene, 23, 3721, 10.1038/sj.onc.1207342 Trushina, 2006, Neurological abnormalities in caveolin-1 knock out mice, Behav. Brain Res., 172, 24, 10.1016/j.bbr.2006.04.024 Van der Stelt, 2005, Cannabinoid receptors and their role in neuroprotection, Neuromol. Med., 7, 37, 10.1385/NMM:7:1-2:037 Van Sickle, 2005, Identification and functional characterization of brainstem cannabinoid CB2 receptors, Science, 310, 329, 10.1126/science.1115740 Xiang, 2002, Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes, J. Biol. Chem., 277, 34280, 10.1074/jbc.M201644200